161 related articles for article (PubMed ID: 24707518)
1. Combined use of inactivated and oral poliovirus vaccines in a large-scale campaign in refugee camps and host communities – Kenya, December 2013.
Wkly Epidemiol Rec; 2014 Mar; 89(12):127-32. PubMed ID: 24707518
[No Abstract] [Full Text] [Related]
2. Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities - Kenya, December 2013.
Sheikh MA; Makokha F; Hussein AM; Mohamed G; Mach O; Humayun K; Okiror S; Abrar L; Nasibov O; Burton J; Unshur A; Wannemuehler K; Estivariz CF;
MMWR Morb Mortal Wkly Rep; 2014 Mar; 63(11):237-41. PubMed ID: 24647400
[TBL] [Abstract][Full Text] [Related]
3. Poliomyelitis vaccines in Belgium: 20 years of experience.
Andre FE
Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
[No Abstract] [Full Text] [Related]
4. Polio.
McFee RB
Dis Mon; 2013 Dec; 59(12):445-7. PubMed ID: 24314810
[No Abstract] [Full Text] [Related]
5. Polio eradication in India: how far are we from reaching the goal?
Banerjee K; Sahu S; Bandyopadhyay S
Indian J Pediatr; 2001 Mar; 68 Suppl 1():S6-14. PubMed ID: 11411387
[No Abstract] [Full Text] [Related]
6. Polio vaccines and polio immunization in the pre-eradication era: WHO position paper.
Wkly Epidemiol Rec; 2010 Jun; 85(23):213-28. PubMed ID: 20545051
[No Abstract] [Full Text] [Related]
7. [Poliomyelitis vaccination in Denmark].
Petersen I
Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028
[No Abstract] [Full Text] [Related]
8. Poliovirus vaccines: live or dead.
Ogra PL; Faden HS
J Pediatr; 1986 Jun; 108(6):1031-3. PubMed ID: 3712146
[No Abstract] [Full Text] [Related]
9. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
Zabicka J
Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
[No Abstract] [Full Text] [Related]
10. Polio vaccines: WHO position paper, January 2014.
Wkly Epidemiol Rec; 2014 Feb; 89(9):73-92. PubMed ID: 24707513
[No Abstract] [Full Text] [Related]
11. [Findings on the success of vaccination and revaccination with live and inactivated vaccines against poliomyelitis].
Dostal V; Haenzel I; Sturm W
Schweiz Med Wochenschr; 1969 Sep; 99(37):1322-4. PubMed ID: 4309326
[No Abstract] [Full Text] [Related]
12. On reducing the risk of vaccine-associated paralytic poliomyelitis in the global transition from oral to inactivated poliovirus vaccine.
Peng X; Hu X; Salazar MA
Lancet; 2018 Aug; 392(10147):610-612. PubMed ID: 29605427
[No Abstract] [Full Text] [Related]
13. Toward eradication of poliomyelitis by combined use of killed and live vaccines.
Melnick JL
Cardiovasc Res Cent Bull; 1982; 20(3):49-60. PubMed ID: 6805957
[No Abstract] [Full Text] [Related]
14. [End phase challenges of poliomyelitis eradication programme realization].
Jarzabek Z
Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
[TBL] [Abstract][Full Text] [Related]
15. Inactivated poliovirus vaccine following oral poliovirus vaccine cessation.
Wkly Epidemiol Rec; 2006 Apr; 81(15):137-44. PubMed ID: 16673508
[No Abstract] [Full Text] [Related]
16. The most ambitious vaccine introduction in history.
Miller E
Vaccine; 2014 Aug; 32(36):4599-601. PubMed ID: 24984120
[No Abstract] [Full Text] [Related]
17. World could be declared free of polio by 2018.
Gulland A
BMJ; 2013 Apr; 346():f2373. PubMed ID: 23585234
[No Abstract] [Full Text] [Related]
18. Benefits and risks of attenuated polio vaccine strains in a community immunized with inactivated polio vaccine.
Rossier E; Phipps PH; Pépin O
Dev Biol Stand; 1979; 43():179-85. PubMed ID: 520669
[No Abstract] [Full Text] [Related]
19. The polio endgame.
Minor P
Hum Vaccin Immunother; 2014; 10(7):2106-8. PubMed ID: 25608050
[TBL] [Abstract][Full Text] [Related]
20. Progress towards global interruption of wild poliovirus transmission, January 2012 – March 2013.
Wkly Epidemiol Rec; 2013 May; 88(18):181-7. PubMed ID: 23696980
[No Abstract] [Full Text] [Related]
[Next] [New Search]